Browse by Journal Title

2024

Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project.
Lange, B., Jaeger, V.K., Harries, M., Rücker, V., Streeck, H., Blaschke, S., Petersmann, A., Toepfner, N., Nauck, M., Hassenstein, M.J., Dreier, M., von Holt, I., Budde, A., Bartz, A., Ortmann, J., Kurosinski, M.A., Berner, R., Borsche, M., Brandhorst, G., Brinkmann, M., Budde, K., Deckena, M., Engels, G., Fenzlaff, M., Härtel, C., Hovardovska, O., Katalinic, A., Kehl, K., Kohls, M., Krüger, S., Lieb, W., Meyer-Schlinkmann, K.M., Pischon, T., Rosenkranz, D., Rübsamen, N., Rupp, J., Schäfer, C., Schattschneider, M., Schlegtendal, A., Schlinkert, S., Schmidbauer, L., Schulze-Wundling, K., Störk, S., Tiemann, C., Völzke, H., Winter, T., Klein, C., Liese, J., Brinkmann, F., Ottensmeyer, P.F., Reese, J.P., Heuschmann, P. and Karch, A.
Infection 52 (1): 139-153. February 2024

2022

Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
Jacob, A.S., Kaul, H., Fuchs, M., Gillessen, S., Kreissl, S., Pluetschow, A., Momotow, J., Schaub, V., Huettmann, A., Haenel, M., Zimmermann, A., Dierlamm, J., Meissner, J., Mathas, S., Martin, S., Engert, A., Hallek, M., Borchmann, P. and Lehmann, C.
Infection 50 (4): 925-932. August 2022

2021

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.
Thibeault, C., Mühlemann, B., Helbig, E.T., Mittermaier, M., Lingscheid, T., Tober-Lau, P., Meyer-Arndt, L.A., Meiners, L., Stubbemann, P., Haenel, S.S., Bosquillon de Jarcy, L., Lippert, L., Pfeiffer, M., Stegemann, M.S., Roehle, R., Wiebach, J., Hippenstiel, S., Zoller, T., Müller-Redetzky, H., Uhrig, A., Balzer, F., von Kalle, C., Suttorp, N., Jones, T.C., Drosten, C., Witzenrath, M., Sander, L.E., Corman, V.M. and Kurth, F.
Infection 49 (4): 703-714. August 2021

2004

Trimethoprim-sulfamethoxazole exacerbates posthypoxic action myoclonus in a patient with suspicion of Pneumocystis jiroveci infection.
Jundt, F., Lempert, T., Doerken, B. and Pezzutto, A.
Infection 32 (3): 176-178. 1 June 2004

2002

Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease.
Reichardt, P., Lehmann, I., Sierig, G. and Borte, M.
Infection 30 : 360-364. 1 December 2002